Ziel des Projekts ist die Identifizierung ursächlicher Sequenzvarianten im Genom von Patienten mit seltenen Erkrankungen.
Support for small and medium-sized life sciences companies to enter challenging global markets.
CE4BIG federates 4 European healthcare clusters, with similar regional smart specialization strategies supporting the development of advanced therapies for personalized medicine.
The Bavarian lighthouse project for digitization in the health sector.
138 partners from 17 European countries collaborate in this EU-funded consortium. The objective of EIT Health is to promote entrepreneurship and innovation in the field of "Healthy Living and Active Aging".
Free training units on the Life Sciences sector and on business culture in eight target countries that are most relevant for biotechnology.
BioM is leading a network of Bavarian biotechnological companies focusing on immunotherapy.
Promoting collaborations between Bavarian biotechnological companies and Japanese pharmaceutical companies as well as scientific institutions in Japan.
Peer2scale, an HORIZON 2020 project, is a peer-learning action between four regional health agencies acting as clusters.
BioM co-ordinates and organizes the "Round Table of Clinical Research" developed within the scope of the Bavarian "Pharmagipfel" conference with representatives of medical centers and the industry.
Start.Smart.Japan is an exclusive, high quality training course that provides a starter kit for executives of European life sciences SMEs, helping them to optimize and accelerate their market entry in Japan.
Start.Smart.Global is a valuable funding opportunity for SMEs to receive support to enter the Japanese and Korean life science markets.